Colorectal cancer liver metastases (CRC-LMs) are associated with poor survival and frequently resist immunotherapy, yet the mechanisms underlying this immune refractoriness remain incompletely defined. Here, we identify a tumor-intrinsic type I interferon (IFN-I)–high state in CRC-LMs associated with loss of the IFN-α/...
A. Castiglioni, A. Monestiroli, G. Delfanti et al.· Science Advances· 0 citations
BACKGROUND
Randomized clinical trials (RCTs) have compared laparoscopic liver resection (LLR) and open liver resection (OLR) for colorectal liver metastases (CRLM); however, long-term outcomes and subgroup effects have not been comprehensively evaluated.
PURPOSE
To compare postoperative and long-term oncologic outcom...
B. Olij, G. Pilz da Cunha, Siân A. Pugh et al.· Annals of Internal Medicine· 0 citations
Sankey analysis showed that early recurrence not always leads to futility, often remaining liver-limited or oligometastatic, often remaining liver-limited or oligometastatic.
R. Marino, Buonanno Silvia, Catena Marco et al.· HPB· 0 citations
It was showed that current prognostic models incompletely capture the biological heterogeneity underlying CRLM recurrence, and dynamic biomarkers and treatment-response indicators may support future multimodal prognostic frameworks and improve risk stratification following curative-intent treatment.
L. Manganaro, Tommaso Russo, L. Novello et al.· Critical reviews in oncology...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.